UBS Maintains a 'Neutral' on Alexion Pharmaceuticals (ALXN); Missed a Step-Up; Neutral on Catalysts
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UBS maintains a 'Neutral' on Alexion Pharmaceuticals (NASDAQ: ALXN) price target raised from $53 to $57.
UBS analyst says, "We acknowledge a quality quarter, albeit aided by a few non-recurring items (+1 shipping day, F/X, Australia launch), and we are raising our above-consensus revenue estimates for 2011-15. However, our DCF- and multiple-based valuations struggle to bring us meaningfully above the current level. That said, we expect over time, numbers will continue to be revised upwards, supporting our positive LT view on ALXN shares. For now, valuation and catalysts keep us Neutral, although a pullback could turn us positive given LT fundamentals." (UBS raises FY11 EPS estimate from $1.11 to $1.16 and FY12 from $1.50 to $1.62)
For more ratings news on Alexion Pharmaceuticals click here and for the rating history of Alexion Pharmaceuticals click here.
Shares of Alexion Pharmaceuticals closed at $56.77 yesterday.
UBS analyst says, "We acknowledge a quality quarter, albeit aided by a few non-recurring items (+1 shipping day, F/X, Australia launch), and we are raising our above-consensus revenue estimates for 2011-15. However, our DCF- and multiple-based valuations struggle to bring us meaningfully above the current level. That said, we expect over time, numbers will continue to be revised upwards, supporting our positive LT view on ALXN shares. For now, valuation and catalysts keep us Neutral, although a pullback could turn us positive given LT fundamentals." (UBS raises FY11 EPS estimate from $1.11 to $1.16 and FY12 from $1.50 to $1.62)
For more ratings news on Alexion Pharmaceuticals click here and for the rating history of Alexion Pharmaceuticals click here.
Shares of Alexion Pharmaceuticals closed at $56.77 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Benchmark Reiterates Buy Rating on Rank One Computing (ROC)
- DA Davidson Starts Everus (ECG) at Buy
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
